Confidence intervals for cost-effectiveness ratios: A comparison of four methods

Health Economics

Volumn 6, Issue 3, 1997, Pages 243-252

  Polsky, Daniel ^a   Glick, Henry A ^a   Willke, Richard ^b   Schulman, Kevin ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PFIZER INC   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Confidence intervals; Economics; Statistics

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE POLICY; INTERMETHOD COMPARISON; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEM ANALYSIS;

COMPUTER SIMULATION; CONFIDENCE INTERVALS; COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; HEALTH SERVICES RESEARCH; HUMANS; MONTE CARLO METHOD; NORMAL DISTRIBUTION; RANDOMIZED CONTROLLED TRIALS; SAMPLING STUDIES; STATISTICS, NONPARAMETRIC; VALUE OF LIFE;

EID: 0030836029     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199705)6:3<243::AID-HEC269>3.0.CO;2-Z     Document Type: Article

References (26)

1. Glick, H. Strategies for economic assessment during the development of new drugs. Drug Inf. J. 1995; 29: 1391-1403.
2. Leaf, A. Cost effectiveness as a criterion for Medicare coverage. N. Engl. J. Med. 1989; 321: 898-900.
3. Commonwealth of Australia. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee, p. 13. Canberra: Woden (ACT) Department of Health, Housing and Community Services, 1992.
4. Ontario Ministry of Health. Guidelines for the Preparation of Economic Analysis to be Included in Submission to Drug Programs Branch for Listing in the Ontario Drug Benefit Formulary/Comparative Drug Index. Toronto: Ministry of Health, 1991.
5. Morris, C. B. and Schulman, K. A. Emerging role of the Food and Drug Administration in pharmacoeconomic evaluation during the drug development process. Drug Inf. J. 1995; 29: 1105-1111.
6. Eisenberg, J. M., Schulman, K. A., Glick, H. and Koffer, H. Pharmacoeconomics: economic evaluation of pharmaceuticals. In: Strom, B. (ed.) Pharmacoepidemiology, 2nd edn, Ch. 32. New York: Wiley, 1994.
7. Drummond, M. F. and Davies, L. M. Economic analysis alongside clinical trials: revisiting the methodological issues. Int. J. Technol. Assess. Health Care 1991; 7: 561-573.
8. Heyse, J. and Cook, J. A New Measure of Cost Effectiveness in Comparative Clinical Economic Trials (Abstract). Boston: American Statistical Association, 1992.
9. O'Brien, B. J., Drummond, M. F., Labelle, R. J. and Willan, A. In search of power and significance: issues in the design and analysis of stochastic cost effectiveness studies in health care. Med. Care 1994; 32: 150-163.
10. van Hout, B. A., Al, M. J., Gordon, G. S. and Rutten, F. F. H. Costs, effects and C/E ratios alongside a clinical trial. Health Econ. 1994; 3: 309-319.
11. Wakker, P. and Klaassen, M. P. Confidence intervals for cost/effectiveness ratios. Health Econ. 1995; 4: 373-381.
12. Mullahy, J. and Manning, W. G. Statistical issues in cost-effectiveness analysis. In: Sloan, F. (ed.) Valuing Health Care. Cambridge: Cambridge University Press, 1995.
13. Willan, A. R. and O'Brien, B. J. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. Health Econ. 1996; 5: 297-305.
14. Manning, W. G., Fryback, D. G. and Weinstein, M. C. Reflecting uncertainty in cost-effectiveness analysis. In: Gold, M. R. Siegle, J. E., Russell, L. B. and Weinstein, M. C. (eds) Cost - effectiveness in Health and Medicine. Oxford: Oxford University Press, 1996.
15. Chaudhary, M. A. and Stearns, S. C. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. Statistics and Medicine 1996; 15: 1447-1458.
16. Freund, J. E. Mathematical Statistics, 2nd edn. Englewood Cliffs, NJ: Prentice-Hall, 1971.
17. Fleiss, J. L. Statistical Methods for Rates and Proportions, 2nd edn. New York: Wiley, 1981.
18. Fleiss, J. L. The Design and Analysis of Clinical Experiments. New York: Wiley, 1986.
19. Gardner, M. J. and Altman, D. G. Estimating with confidence. British Medical Journal 1988; 296: 1210-1211.
20. Schulman, K. A., Lynn, L. A., Glick, H. A. and Eisenberg, J. M. Cost effectiveness of low-dose Zivodudine therapy for asymptomatic patients with human immunodeficiency virus (HIV) infection. Annals of Internal Medicine 1991; 114: 798-802.
21. Armitage, P. Statistical Methods in Medical Research. New York: Wiley, 1971.
22. Efron, B. and Tibshirani, R. J. An Introduction to the Bootstrap. New York: Chapman & Hall, 1993.
23. Efron, B. Bootstrap methods: another look at the jackknife. Ann. Statist. 1979; 7: 1-26.
24. Efron, B. Better bootstrap confidence intervals. J. Am. Stat. Assoc. 1987; 82: 171-200.
25. Fieller, E. C. Some problems in interval estimation with discussion. J. Royal Stat. Soc., Series B 1954; 16: 175-188.
26. Sox, H. C., Blatt, M. A., Higgins, M. C. and Marton, K. I. Medical Decision Making. Boston: Butter-worth-Heinemann, 1988.